NCT00090766View on ClinicalTrials.gov

A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Cytomegalovirus Infections

Interventions

DRUG

valganciclovir [Valcyte]

po daily (dose based on body surface area and CrCL)

Trial Locations (17)

3050

Parkville

10029

New York

13353

Berlin

28041

Madrid

28046

Madrid

44340

Guadalajara

46009

Valencia

63110

St Louis

75019

Paris

75743

Paris

90095-1752

Los Angeles

46202-5124

Indianapolis

48109-0297

Ann Arbor

84132-2806

Salt Lake City

T6G 2R7

Edmonton

R3A 1S1

Winnipeg

06720

Mexico City

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00090766 - A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients | Biotech Hunter | Biotech Hunter